When Kang Went Back To The FDA With His Irradiated, Poisoned, Mutant Virus, “the FDA Suggested We Should Use HIV-positive Individuals, Because The Main Objective Of A Human Phase I Clinical Trial Is Safety,” He Says | #[732] Kang Went Back To The FDA With His Irradiated # Poisoned # Mutant Virus # “the FDA Suggested We Should Use HIV-positive Individuals # Because The Main Objective Of A Human Phase I Clinical Trial Is Safety #[733] He Says